Search

Search Results

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  Published:

  1131

  PDF: 867

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  Published:

  1421

  PDF: 904

• Comorbidities in rheumatoid arthritis: analysis of hospital discharge records

  M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino

  154-160

  11-04-2005

  Published: 11 April 2005

  1968

  PDF: 1347
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  Published: 10 April 2020

  1247

  PDF: 662
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  Published: 9 November 2011

  1908

  PDF: 1466

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  Published:

  1636

  PDF: 1906

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  Published:

  926

  PDF: 2904

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  Published:

  1036

  PDF: 713

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  Published:

  738

  PDF: 2151

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  Published:

  1336

  PDF: 928

• Prevalence of anti-CCP antibodies in systemic sclerosis

  M. Marrone, A. Chialà, M. Tampoia, F. Iannone, L. Raho, M. Covelli, V. Grattagliano, N. Pansini, G. Lapadula

  20-24

  Published:

  1058

  PDF: 804

• Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

  M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli

  94-103

  Published:

  1270

  PDF: 894
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  Published: 22 May 2017

  4098

  PDF: 2909
• 

  Cardiovascular involvement in psoriatic arthritis

  F. Atzeni, M. Turiel, L. Boccassini, S. Sitia, L. Tomasoni, M. Battellino, A. Marchesoni, V. De Gennaro Colonna, P. Sarzi-Puttini

  148-154

  09-11-2011

  Published: 9 November 2011

  1701

  PDF: 916

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  Published:

  1311

  PDF: 859

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  Published:

  917

  PDF: 744

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  Published:

  996

  PDF: 1548
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  Published: 19 November 2020

  1400

  PDF: 949

• Magnetic resonance imaging of the peripheral joints in psoriatic arthritis

  M.C. D'Auria, R. Scarpa, M. Parodi, E. Silvestri, G. Garlaschi, M.A. Cimmino

  6-14

  Published:

  1224

  PDF: 914

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  Published:

  1964

  PDF: 798

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  Published:

  931

  PDF: 3758

• A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome

  P. Fadda, L. La Civita, A.L. Zignego, C. Ferri

  316-323

  Published:

  1146

  PDF: 2405
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  Published: 28 January 2020

  1632

  PDF: 776

• CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW

  N.J. Mchugh, E.R. Soriano

  81-84

  Published:

  702

  PDF: 701

• Soluble P-selectin levels in synovial fluid and serum from patients with psoriatic arthritis

  R. Scrivo, A. Spadaro, V. Riccieri, M. Bombardieri, M. Di Franco, D. Celestino, G. Valesini

  250-255

  Published:

  959

  PDF: 649

• Hidden bone erosions

  E. Filippucci, A. Farina, F. Salaffi, W. Grassi

  52-55

  Published:

  998

  PDF: 4727

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  Published:

  1459

  PDF: 682
• 

  Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and a review of the literature

  E. Yılmaz

  19-12-2023

  Published: 19 December 2023

  1490

  PDF: 396

• New classification criteria for rheumatoid arthritis

  C.A. Scirè, R. Caproali

  159-162

  Published:

  1809

  PDF: 8885

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  Published:

  818

  PDF: 1953

• Synoviocyte cultures from synovial fluid

  A. Scanu, F. Oliviero, L. Braghetto, R. Ramonda, R. Luisetto, F. Calabrese, A. Pozzuoli, L. Punzi

  66-70

  Published:

  1562

  PDF: 1000

• Sonographic findings of the synovial fluid

  A. Farina, E. Filippucci, W. Grassi

  261-265

  Published:

  1128

  PDF: 1584

• Metabolic syndrome in inflammatory rheumatic diseases

  D. Malesci, G. Valentini, G. La Montagna

  169-176

  Published:

  1603

  PDF: 3801

• Recombinant adenovirus-mediated gene transfer suppresses experimental arthritis

  E. Quattrocchi, M. Feldmann

  46-54

  Published:

  648

  PDF: 687
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  Published: 29 December 2022

  678

  PDF: 282

• Rheumatic diseases at the court of the Medici of Florence: the so-called “gout” of the Medici

  G. Fornaciari, V. Giuffra

  229-237

  Published:

  1008

  PDF: 767

• IMAGING OF PSORIATIC ARTHRITIS

  I. Olivieri, E. Scarano, A. Padula, S. D'Angelo

  73-76

  Published:

  1168

  PDF: 1003

• Psoriatic arthritis as a mountain

  J.M. Berthelot

  6-15

  Published:

  864

  PDF: 881

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  Published:

  1828

  PDF: 1038

• A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

  Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini

  22-25

  Published:

  1455

  PDF: 1939

• MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

  P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

  132-139

  Published:

  1807

  PDF: 1103
• 

  Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis

  D.J. Manzella, L. Vicente, A.A. Pérez de la Hoz, R.J. Zamora, G. De Rosa, A.A. Pisarevsky

  92-98

  09-07-2019

  Published: 9 July 2019

  1228

  PDF: 932

• LABORATORY FINDINGS IN PSORIATIC ARTHRITIS

  L. Punzi, M. Poswiadek, F. Oliviero, A. Lonigro, V. Modesti, R. Ramonda, S. Todesco

  52-55

  Published:

  2033

  PDF: 1290

• The arthropathy of systemic sclerosis

  D. Malesci, G. La Montagna, G. Valentini

  232-237

  Published:

  29016

  PDF: 2039
• 

  The clinical manifestations at the onset of antisynthetase syndrome: A chameleon with multiple faces

  A.C.C.D. Baccaro, G.L. Behrens Pinto, R.C.S. Carboni, S.K. Shinjo

  86-92

  23-07-2020

  Published: 23 July 2020

  1149

  PDF: 742

• Septic arthritis: a 12 years retrospective study in a rheumatological university clinic

  M. Favero, F. Schiavon, L. Riato, V. Carraro, L. Punzi

  260-267

  Published:

  1516

  PDF: 1126
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  Published: 19 December 2023

  1550

  PDF: 348

• Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative”

  F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini

  34-45

  Published:

  1946

  PDF: 2202

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  3-7

  Published:

  1097

  PDF: 710
• 

  Poncet’s disease diagnostic criteria decodes conundrum: Poncet’s vs pseudo Poncet’s

  V. Shobha, A.M. Desai

  46-50

  01-04-2019

  Published: 1 April 2019

  1332

  PDF: 1000